Please login to the form below

Not currently logged in
Email:
Password:

dysphagia

This page shows the latest dysphagia news and features for those working in and with pharma, biotech and healthcare.

Nestlé Health Science invests $145m in food allergy biotech

Nestlé Health Science invests $145m in food allergy biotech

These include Nestlé's $1.9bn partnership on potential inflammatory bowel disease treatments and the acquisition of UK medical device firm and dysphagia specialist Phagenesis..

Latest news

  • Nestlé Health Science buys medical device firm Nestlé Health Science buys medical device firm

    Greg Behar, chief executive at Nestlé Health Science, said: “ Dysphagia is a strategic focus for Nestlé Health Science. “ ... If left untreated, dysphagia can lead to life-threatening complications, including aspiration pneumonia, dehydration and

  • The problem with pills The problem with pills

    The natural tendency is to assume that problems such as dysphagia are more common in the elderly, and indeed 44% of participants aged 65 years or older reported these difficulties.

  • VCCP Health and Havas Life Medicom tie for first at PM Society Awards VCCP Health and Havas Life Medicom tie for first at PM Society Awards

    Meanwhile the ceremony saw Havas Life Medicom, which picked up three Gold trophies, rewarded for its dysphagia awareness work on behalf of clinical nutrition company Fresenius Kabi.

  • IPA Best of Health Awards

    Rosemont - Dysphagia. Rainmaker Advertising. Seroquel - Turn First. Langland. Symbicort - Cook/Painter/Teacher/Policeman. ... Roundhouse Healthad. Protelos - Ladies. Paling Walters. Rosemont - Dysphagia. Rainmaker Advertising.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics